Author response: ORMDL3 restrains type-I interferon signaling and anti-tumor immunity by promoting RIG-I degradation

Qi Zeng(Sun Yat-sen University), Shuai Chen(Sun Yat-sen University)
Unknown
October 7, 2024
Cited by 0


Related Papers